SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-20-000020
Filing Date
2020-02-18
Accepted
2020-02-18 06:36:36
Documents
10
Period of Report
2020-02-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a202002188k.htm 8-K 52730
2 EXHIBIT 10.1 a202002188kexhibit101.htm EX-10.1 191713
3 EXHIBIT 10.2 a202002188kexhibit102.htm EX-10.2 99401
4 EXHIBIT 10.3 a202002188kexhibit103.htm EX-10.3 268647
5 EXHIBIT 10.4 a202002188kexhibit104.htm EX-10.4 114803
6 EXHIBIT 10.5 a202002188kexhibit105.htm EX-10.5 121109
7 EXHIBIT 10.6 a202002188kexhibit106.htm EX-10.6 311934
8 EXHIBIT 10.7 a202002188kexhibit107.htm EX-10.7 121076
9 EXHIBIT 99.1 a202002188kexhibit991.htm EX-99.1 16156
10 prlogo.jpg GRAPHIC 3568
  Complete submission text file 0000819050-20-000020.txt   1303916
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 20623320
SIC: 2836 Biological Products, (No Diagnostic Substances)